Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.
तुलना करने के लिए मीट्रिक्स | VIMIAN | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधVIMIANपीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | 216.5x | −1.4x | −0.6x | |
PEG अनुपात | 1.33 | −0.01 | 0.00 | |
क़ीमत/बुक | 3.1x | 2.3x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 6.2x | 10.2x | 3.2x | |
अपसाइड (विश्लेषक लक्ष्य) | 8.0% | 67.1% | 46.5% | |
उचित मूल्य अपसाइड | अनलॉक करें | 16.5% | 6.6% | अनलॉक करें |